(Group M, n = 30) as premedicants, using a double-blind study design. Sedation and anxiolysis were evaluated using a sedation and cooperation scale and recorded at several time points.
R Re es su ul lt ts s: : Acceptable conditions (K1: 23; K2: 26, M: 19) for parental separation were not different between groups. Induction conditions were acceptable in 26 patients in K2 (P < 0.05 vs M) (K1: 23; M: 19). Compared to baseline values individual conditions significantly improved in groups K1 and K2 from 2.5 min after premedication until induction of anesthesia (P < 0.003), in group M conditions improved only five minutes after premedication (P < 0.05). Adverse effects observed in this series were within an acceptable range and similar for the three groups.
C Co on nc cl lu us si io on n: : Intranasal administration of s-ketamine and midazolam is an appropriate premedication in preschool children. they show a rather slow onset of sedation, and first pass hepatic metabolism results in a low and unpredictable systemic availability. 6, 7 Furthermore both rectal and oral routes can be used successfully only in children who generally accept premedication, otherwise either spitting out (oral route) or immediate defecation (rectal route) may result.
Objectif : Évaluer l'efficacité et l'innocuité de l'administration intranasale de s-kétamine et de midazolam comme prémédication chez des patients pédiatriques.

Méthode : L'étude à double insu a porté sur
Intranasal midazolam for premedication in preschool children was first described and advocated by Wilton and colleagues. 8 Racemic ketamine as a premedicant has been successfully administered via the nasal route 9,10 as well. Combinations of midazolam and ketamine given orally 11, 12 or rectally 4 have been shown to result in better premedication than either drug alone.
Audenaert and colleagues 13 investigated the cardiac effects of different pediatric premedication regimes and recommended the combination of intranasally administered ketamine 5 mg·kg -1 and midazolam 0.2 mg·kg -1 especially in children with tenuous cardiocirculatory status. Data concerning the sedative effects of this concept have not been published.
S-ketamine, one of the two ketamine isomers is now available in Germany. S-ketamine has twice the anesthetic potency of racemic ketamine.
14 Thus, a 50% reduction of dosage is possible to achieve comparable results. Because of faster elimination of s-ketamine, better control of anesthesia will be provided. 15 Furthermore it produces less psychomimetic side effects than racemic ketamine 16 because these are mainly caused by r-ketamine 17 the other enantiomer of racemic ketamine.
Considering the effects of intranasally administered s-ketamine and midazolam for pediatric premedication remain unclear, we conducted a prospective randomized double-blind clinical trial. The purpose of this study was to evaluate the efficacy and safety of three different regimes for pediatric premedication. We compared the sedative and anxiolytic effects of two different doses of intranasally administered s-ketamine (1 or 2 Premedication was given to the children on the ward by a nurse or the parents, using a syringe of appropriate size (1/2/5 mL) without a needle. The whole volume was given into one nostril while the child was either sitting on the parent's lap or on the bed. During the whole study period oxygen saturation and heart rate were continuously monitored using a portable pulse oximeter (Oxycount®mini, Andos, Karlsruhe, Germany). After inhalational induction of anesthesia with sevoflurane 8% and N 2 O in 50% O 2 , the airway was secured by endotracheal intubation or placement of a laryngeal mask. The children were then mechanically ventilated to normocapnia with N 2 O in 30% O 2 and sevoflurane as necessary. Intraoperatively no additional opioids or iv sedatives were given. At the end of surgery sevoflurane delivery was discontinued and mechanical ventilation was continued with 100% oxygen. All patients were extubated awake. Postoperative analgesia was provided by either rectal paracetamol 20 mg·kg -1 or regional anesthesia as appropriate. Sedation and anxiolysis were evaluated in untouched patients. For additional evaluation of cooperation (placement of the pulse oximetry sensor, electrocardiogram electrodes and mask induction of anesthesia) the score was modified.
Sedation was estimated by a single observer according to a sedation scale adapted from Wilton and colleagues, 8 who performed a composite evaluation based on sedation, anxiolysis and cooperation, leading to the determination of a "sedation level" scored 1 to 5 (Table  I) . Sedation was assessed in "untouched children" 2.5 and five minutes after drug administration, immediately after separation from the parents (ten minutes after drug administration) and immediately after the arrival in the postanesthetic care unit (PACU). As did Wilton and colleagues, we modified the scoring-system to assess the acceptance of direct manipulations. Sedation, anxiolysis and cooperation were recorded immediately before intranasal drug administration (baseline value), during placement of the anesthesia monitoring devices (electrocardiogram, pulse oximetry) and during mask induction of general anesthesia.
For statistical analysis the sedation scale values were condensed to a variable consisting of three categories: unacceptable conditions (levels 1 and 2), acceptable conditions (levels 3 and 4) and unacceptable deep sedation (level 5).
Patients with a time interval longer than 120 min between premedication and the end of anesthesia were excluded from postoperative assessment of the sedation scores.
Heart rate was monitored by continuous pulse oximetry throughout the study period to detect possible cardiovascular effects of premedication. We did not measure blood pressure because this procedure often causes discomfort, which might lead to interference with the assessment of anxiolysis and sedation.
Immediate reactions to premedication were recorded. Adverse effects, if any, especially odd behaviour or unexplained distress and excessive salivation, were recorded.
Sample size determination and statistical analysis
Our study was designed to detect an increase in the rate of acceptable conditions (sedation scale levels 3 and 4) for separation and induction from 76% to 95% with a power of 80% and an alpha error of less than 5%. The 76% success rate was taken from a study by Wilton (Table II) . Ten patients (K1: 5; K2: 1; M: 4) were excluded from postoperative evaluation, because their premedication-extubation time interval exceeded 120 min. Intragroup comparison of changes in sedation scores of individual patients at different times against baseline values showed significantly improved sedation conditions in groups K1 and K2 from 2.5 min after premedication until induction of general anesthesia, whereas in group M conditions improved only five minutes after premedication (Table III) .
Intergroup comparison vs group M did not reveal better sedation conditions for group K1 at any time. Patients in group K2 presented with significantly better conditions from five minutes after premedication until induction except for separation from the parents (Figure 1 ).
Ten patients in group K2 had a sedation level of 1 immediately before premedication (K1: 3, M: 5). During induction of general anesthesia there were no patients in group K2 presenting with a sedation level of 1 (K1: 4, M: 7).
Changes in heart rate, compared to baseline values showed significantly higher values at induction and after arrival in the recovery room for groups K1 and M. In group K2 heart rates were significantly lower five minutes after premedication and during separation from the parents (Figure 2 ). Mean heart rates were lower than baseline values in group K2 throughout the study period.
Oxygen saturation was $ 96% throughout the whole observation period in all children.
Side effects
Immediately after drug administration all patients complained either verbally (bitter taste) or non-verbally (infants and toddlers). These complaints lasted less than 2.5 min in all patients. None of the 90 children reached a sedation level of 5, which represents deep sedation. Excessive salivation did not occur. D Di is sc cu us ss si io on n In our study midazolam 0.2 mg·kg -1 [Group M] led to good conditions for separation and induction in 73% and 63% of patients respectively. Wilton and colleagues 8 administered midazolam 0.2 mg·kg -1 nasally for premedication in preschool children. Defining sedation levels higher than 1 (agitated) as successful premedication they achieved good conditions for parental separation and inhalational induction of general anesthesia in 93% of their patients. Applying our criteria for successful premedication (sedation levels 3 and 4) to their data leads to success rates of 73% for separation and 80% for induction.
The combination of midazolam 0.2 mg·kg -1 and sketamine 1 mg·kg -1 (K1) did not significantly improve sedation and cooperation conditions when compared to group M. Conditions in group K2 were significantly better compared to group M from five minutes after premedication until induction except for parental separation. Individual sedation scores improved significantly in groups K1 and K2 from 2.5 min after premedication until induction of general anesthesia.
Only in group K2 was there no child presenting with a sedation level of 1 during induction of general Weber et al.: PREMEDICATION IN CHILDREN 473 FIGURE 1 Patients with acceptable sedation levels at different observation times (*P < 0.05 intergroup difference vs Group M).
FIGURE 2 Changes of mean heart rate, in percent compared to baseline value (100%) immediately before premedication (*P < 0.05 intragroup difference vs baseline values).
anesthesia (K1: 4, M: 7). On the other hand, ten children were scored level 1 in group K2 immediately before premedication (K1: 3, M: 5). Due to the predetermined classification of the sedation scores (1 and 2: unacceptable, 3 and 4: acceptable, 5: unacceptable deep sedation) this was not taken into account for statistical analysis, but might suggest the superiority of the K2 combination compared to groups K1 and M. The evolution of individual sedation levels during the study period (Table III) shows a tendency from acceptable conditions before premedication (baseline) to unacceptable conditions for parental separation and induction in groups M and K1. Only in group K2 were conditions for parental separation and induction identical or better compared to baseline values in all 30 children studied. In our opinion it is more important to assess the evolution of the behavioural status under different degrees of emotional stress (baselineseparation -induction) than to look at overall numbers of sedation levels irrespective of the individual evolution of sedation or agitation.
The evolution of heart rate after premedication ( Figure 2) indicates that nasally applied s-ketamine 2 mg·kg -1 does not induce clinically detectable sympathomimetic effects. In contrast to groups M and K1, in group K2 mean heart rate was lower throughout the entire study period compared to baseline values (P < 0.05, five minutes after premedication and after separation from the parents). In groups M and K1 there was a significant rise in mean heart rate during induction and after arrival in the PACU. These findings parallel the larger number of children with unacceptable sedation scores during induction and after arrival in the PACU in groups M and K1.
Our study supports the data presented by Audenaert and colleagues 13 who found that the combination of intranasally administered racemic ketamine 5 mg·kg -1 and midazolam 0.2 mg·kg -1 did not produce significant cardiovascular and respiratory side effects. Taking into account that racemic ketamine has approximately half the potency of s-ketamine, 14 this dosage is comparable to our group K2.
Louon and Reddy 18 used a mixture of ketamine 5 mg·kg given intranasally to induce deep sedation for computerized tomography. As intended by the investigators, two thirds of the patients fell asleep with stable vital signs within five to 20 min after drug administration. The aim of our study was not to obtain deep sedation but to produce calm, fully awake and cooperative children. In our study no child presented deep sedation.
Sample size for this study was calculated to examine efficacy, not safety. Thus, we can only state that, based on this limited study, no serious complications were encountered. This and previously published studies on nasal ketamine and midazolam in children [8] [9] [10] 13, 18 without any reports of serious complications are no formal safety proof. One theoretical serious complication would be the penetration of s-ketamine and midazolam through the cribriform plate, giving rise to high central nervous system levels. However, serious complications are likely very rare and a very large study size would be required to demonstrate safety conclusively. Because of the very rapid onset of sedation we recommend the use of a pulse oximeter and continuous observation of the child after nasal premedication.
All 90 patients complained of the bitter taste of the premedication, but these complaints were very shortlived, lasting less than 2.5 min after premedication. We did not observe any other adverse effect.
A possible criticism of our study might be that we used volumes of 0.8-1.2 mL·kg -1 for intranasal drug administration. Apart from drug absorption over the nasal mucosa, significant parts of the medication will go to the pharynx where absorption via the pharyngeal mucosa occurs and the remaining volume will be swallowed. Thus we must emphasize that the term nasal premedication describes the mode of drug administration and not necessarily the single route of drug absorption.
In conclusion, nasal administration of s-ketamine and midazolam to preschool children provides good conditions for induction of anesthesia; furthermore it shows a very rapid onset of action without evidence of serious adverse effects. This premedication regime may be an alternative to any of those that have been reported over the last two decades in children where a rapid onset of anxiolysis and sedation is desired.
